EXCNEUTRAL

P/E Ratio

16.7x

Updated 656h ago

Sector Performance

28th percentile

EXC

16.7x

Sector Median

24.7x

Sector Avg

36.0x

📊

Deep Analysis

The current price-to-earnings (P/E) ratio of 16.7x means investors are paying $16.70 for every $1.00 of the company’s annual earnings.

This is well below the sector median of 25.1x, placing the stock in the 20th percentile among peers—indicating it is cheaper than 80% of comparable companies. The trend data is not available: the year-over-year change is N/A, and the quarter-over-quarter change is N/A, so no directional insight can be drawn from the metric's movement. The combination of a low P/E relative to the sector with no trend information suggests the stock may offer a valuation discount, but the lack of historical context leaves uncertainty about whether this discount is justified or persistent. This metric supports the overall NEUTRAL verdict because a below-median P/E could imply an undervalued opportunity, yet without trend confirmation, it does not provide enough evidence for a bullish or bearish stance on its own.

Frequently Asked Questions

What does the P/E Ratio tell investors about EXC?

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

How is the P/E Ratio calculated?

P/E Ratio is calculated as: Price / EPS.

Who are EXC's closest peers by P/E Ratio?

The closest peers by P/E Ratio include: VICI (9.1x), OMF (9.0x), JACK (8.5x), GIS (8.4x), FIS (8.4x).

The Formula

Price / EPS

Why It Matters

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

Advertisement

Master EXC's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full EXC research report

Free account — no credit card

EXC

16.7x

Sector Median

24.7x

Sector Avg

36.0x

How EXC's P/E Ratio compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.